Seven Grand Managers’s Veradermics MANE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.2M Hold
125,000
– – 0.55% 33
2026
Q2
$15.4M Buy
125,000
+50,250
+67% +$4.71M 0.62% 34
2026
Q1
$4.72M Buy
+74,750
New +$3.77M 0.32% 76

Other funds holding MANE

Seven Grand Managers's MANE Position: Q3 2026 in Review

Seven Grand Managers held its Veradermics (MANE) position steady in Q3 2026 at 125,000 shares worth $15.2M. The position accounts for 0.55% of the portfolio, ranked #33.

Seven Grand Managers first reported a position in MANE in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.4M in Q2 2026. 208 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • Seven Grand Managers held 125,000 shares of Veradermics worth $15.2M as of Q3 2026.
  • Seven Grand Managers left its Veradermics share count unchanged in Q3 2026.
  • Veradermics made up 0.55% of Seven Grand Managers's portfolio in Q3 2026, its #33 holding.
  • Seven Grand Managers first reported a position in Veradermics in Q1 2026 and has held it in 3 quarters since.
  • Seven Grand Managers's Veradermics position peaked at $15.4M in Q2 2026.
  • 208 funds tracked by Wall St. Rank held Veradermics as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.